Genmab — August 2018

[E_L]

yes, thanks Stockbull, keep talking

[JKY_VH]

Jep, fortsæt den gode stil SB

[StockBull]

Also Darzalex has shown some encouraging early data in Amyloidosis that also seems NOT reflected in present share price. Not sure how big the marked is but I recon it could be around 500 mil USD at least

[StockBull]

Also looking forward to update on RA at CMD that Genmab are hosting on 26th September at their new R&D headquarters in Utrecht, Netherland as well as how Genmab see the Darzalex market developing as well as a focus on the early stage proprietary programme including updates on Tisotumab Vedotin, AXL-ADC, CD3xCD20 and DR5:DR5 Hexabod

[StockBull]

Also we hopefully have in near future EMA 1st line approval.
Not sure I have anymore in my sleeve today

[kkjoel]

Ja, det er kønt brølet, SB. Keep up the good broeling

[JKY_VH]

SB 12:52 jeg mener at have set tal herinde svarende til 10% af MM-markedet.

[Bulder]

Lidt mere. MM estimat 2018 30.770 i USA. Amy 4500. http://amyloidosis.org/facts/al/

[Bulder]

Så hvis alt går vel, ligger der måske en lille BB i Amy.

[JKY_VH]

Tak Bulder og alt tyder jo på, at dara virker rigtig godt ift Amyloidosis.

[Helge_LarsenPI-redaktør]

https://play.borsen.dk/social/5b835bcab1ac14e30ab6d886

[nik_hs1990]

Tænker i resultater fra Mai studiet kan lande når som helst? Krydser selvfølgelig fingre og satser på gode data.

[pauly]

Ja når som helst, det er det vi venter på

[nik_hs1990]

Puha bliver spændende, mildest talt.

[Helge_LarsenPI-redaktør]

Måske en ny Genmab: https://borsen.dk/nyheder/virksomheder/artikel/1/367862/gammelt_genmab-hold_proever_boerslykken_i_usa_vil_rejse_knap_600_mio.html?utm_source=forside&utm_campaign=nyhed_12

[StockBull]

Morning

[StockBull]

https://twitter.com/fezziwig2008/status/1033417043503140864

[StockBull]

https://twitter.com/SparkCures/status/1034121866212986880

[Jazzz]

@Helge, hvilken artikel i Børsen linker du til? (Den render blot ind på forsiden til elbiler)

[transalp]

Go morgen..